Wanbury
WANBURYNSE

Wanbury

₹258.55-2.05 (0.79%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
253.55
Today’s high
264.40
52 week low
161.50
52 week high
329.70
Open price
260.60
Previous close
260.60
Live volume
38,129
Lower circuit
247.60
Upper circuit
273.60

Fundamentals

Market Cap
₹918Cr
ROE
51.51%
P/E Ratio(TTM)
21.37
EPS(TTM)
12.30
P/B Ratio
11.86
Dividend Yield
0.00%
Industry P/E
34.55
Book Value
22.16
Debt to Equity
2.98
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹163
+1.48%
Profit (Cr)
₹15.76
+3.82%
050100150200
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+21%
3Y CAGR+6%
Profit growthValue
1Y (TTM)+1,192%
3Y CAGR-28%

About

Wanbury Limited is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (API) and Formulations. It is one of the world's largest producers of Metformin (anti-diabetic). The company successfully completed its first commercial shipment of high-potency anaesthetic APIs to the European market from its state-of-the-art Tanaku facility.;
CEO/MD
NA
Founded in
1988
NSE symbol
WANBURY

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
56.12%
Promoters
43.02%
Foreign Institutions
0.86%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹373.00
-4.50 (1.19%)
L
    H
    4,113.4485.9915.56
    ₹399.50
    -4.55 (1.13%)
    L
      H
      3,775.5842.135.18
      Orchid PharmaORCHPHARMA
      ₹719.25
      +23.70 (3.41%)
      L
        H
        3,525.74186.872.77
        Aarti DrugsAARTIDRUGS
        ₹362.35
        -5.50 (1.50%)
        L
          H
          3,349.6116.552.28
          Livesquawk
          Wanbury's Q3 EBITDA rose to ₹267M from ₹139M YoY, reflecting strong growth. Q3 EBITDA margin improved to 16.4% from 10.5% YoY, showcasing efficiency gains.
          2026
          29
          May
          Quarterly & Annual Result
          Upcoming
          Release date
          14
          May
          Quarterly & Annual Result
          Today
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          4
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks